Digital Screening for Atrial Fibrillation to Prevent Stroke

Recruiting now · Not applicable

Conditions studied: Atrial Fibrillation (Prevention of Stroke), Stroke

In brief

The Austrian Digital Heart Study is a population-based, siteless, randomized, controlled digital trial testing whether a smartphone-based atrial fibrillation screening and management pathway reduces stroke hospitalizations compared with usual care. Adults aged 65 years or older in Austria are randomized to either a digital intervention using the 'Pulskontrolle' app or to usual care. The intervention includes smartphone-camera photoplethysmography for atrial fibrillation screening, confirmatory 7-day ECG patch monitoring in case of suspected atrial fibrillation, and digital education and management support. The primary outcome is hospitalization for stroke of any type within 48 months.

Key facts

Study ID

NCT07684053

Run by

Medical University Innsbruck

People needed

100060

Starts

2026-06-29

Expected to finish

2032-06-01

Last updated by the study team

2026-07-06

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 65 years
• Policyholder in Austria (active unique social insurance number)
• Written electronic informed consent Exclusion Criteria
• a) Currently treated with oral anticoagulation b) Cardiac implanted electronic device (CIED)

Where it is running

• Department of Internal Medicine III, Medical University Innsbruck — Innsbruck, Tyrol, Austria (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.